Financhill
Back

Marker Therapeutics Stock Predictions

Marker Therapeutics Stock Forecast

  • Is Marker Therapeutics Stock Undervalued?
    The current Marker Therapeutics [MRKR] share price is $2.79. The Score for MRKR is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • MRKR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Marker Therapeutics Stock Go Up Next Year?

Data Unavailable

Marker Therapeutics Stock Rating

Data Unavailable

Marker Therapeutics Stock Price History

Is MRKR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRKR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
http//www.markertherapeutics.com

52-Week Data

52-Week High:
6.16
52-Week Low:
2.40

Prediction Charts

Market Cap:
24.89M
Price in USD:
2.79
Volume:
33.49K
Beta:
3.33

Technical Analysis

SMA50:
4.06
SMA100:
4.15
SMA200:
4.23
52-Wk Change:
-47.95%

Stock Predictions

  • Is Marker Therapeutics stock public?
    Yes, Marker Therapeutics is a publicly traded company.
  • What is the Marker Therapeutics stock quote today?
    The Marker Therapeutics stock price is 2.79 USD today.
  • How to buy Marker Therapeutics stock online?
    You can buy Marker Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-28 3.53 3.54 3.72 3.35
Aug-29 3.49 3.50 3.76 3.46
Aug-30 3.50 3.61 3.61 3.40
Sep-3 3.45 3.00 3.54 3.00
Sep-4 3.15 3.08 3.36 3.00
Sep-5 3.09 3.13 3.23 2.90
Sep-6 3.11 2.98 3.20 2.77
Sep-9 2.89 3.08 3.14 2.89
Sep-10 3.16 2.70 3.25 2.57
Sep-11 2.72 2.78 3.24 2.65
Sep-12 2.68 2.70 2.89 2.61
Sep-13 2.83 2.77 2.95 2.72
Sep-16 2.77 2.88 2.96 2.75
Sep-17 2.86 2.79 3.00 2.75

Marker Therapeutics Earnings

Data Unavailable

Marker Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.

* Marker Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.